Cynthia L. Toze

University of British Columbia — Canada

Medicine · Health Sciences

32h-index3.3kcitations97works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(37), Chronic Lymphocytic Leukemia Research(33), Acute Myeloid Leukemia Research(28), Hematopoietic Stem Cell Transplantation(22), Chronic Myeloid Leukemia Treatments(18)

Publications97 total

Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population
Blood·2025Open Access
CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization
Blood·2024Open Access
Richter Transformation (RT) in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Comparison of Two Eras
Blood·2024· 1 cited
British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib
Blood·2023Open Access
Granulomatous Myositis as a Manifestation of Chronic Graft-Versus-Host Disease: A Case Series and Review of the Literature
Clinical Lymphoma Myeloma & Leukemia·2022· 6 cited
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma
Blood Advances·2020· 31 citedOpen Access
Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada
Leukemia Research·2019· 2 cited
High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation
Bone Marrow Transplantation·2018· 11 cited
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis
Clinical Lymphoma Myeloma & Leukemia·2018· 15 cited
Excellent real‐world outcomes of adults with Burkitt lymphoma treated with <scp>CODOX</scp>‐M/<scp>IVAC</scp> plus or minus rituximab
British Journal of Haematology·2018· 23 citedOpen Access
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience
Biology of Blood and Marrow Transplantation·2018· 23 citedOpen Access
Updates from the 2017 American Society of Hematology Annual Meeting: Practice-Changing Studies in Untreated Chronic Lymphocytic Leukemia
Current Oncology·2018· 1 citedOpen Access
Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation
Blood·2017· 1 cited
Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada
Leukemia & lymphoma/Leukemia and lymphoma·2017· 10 cited
CD56 <sup>bright</sup> natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- <i>versus</i> -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results
Haematologica·2017· 22 citedOpen Access
Regulatory T-cells drive immune dysfunction in CLL
Leukemia & lymphoma/Leukemia and lymphoma·2017· 23 cited
OUTCOME OF PATIENTS WITH RELAPSED AND REFRACTORY PERIPHERAL T CELL LYMPHOMA INTENDED FOR STEM CELL TRANSPLANT
Hematological Oncology·2017Open Access
Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada
Clinical Lymphoma Myeloma & Leukemia·2017· 8 cited
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Annals of Hematology·2017· 27 citedOpen Access
Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada
Leukemia Research·2017· 8 cited
page 1 of 5Next →

Frequent Co-authors

Donna E. Hogge(34), Thomas J. Nevill(29), Donna L. Forrest(27), John D. Shepherd(25), Michael J. Barnett(23), Kevin Song(23), Heather J. Sutherland(23), Stephen H. Nantel(20), Julye C. Lavoie(17), Clayton A. Smith(16), Joseph M. Connors(13), S.H. Nantel(10), Maryse Power(10), Raewyn Broady(10), Sujaatha Narayanan(8), Randy D. Gascoyne(7), Nicholas Voss(7), Alina S. Gerrie(7), Douglas E. Horsman(6), H.J. Sutherland(6)